Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease

Neurobiology of Aging

Volumn 24, Issue 8, 2003, Pages 1063-1070

  Oddo, Salvatore ^a   Caccamo, Antonella ^a   Kitazawa, Masashi ^a   Tseng, Bertrand P ^a   LaFerla, Frank M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloid; A ; Presenilin; Tangles; Tau; Transgenic; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MEMBRANE PROTEIN; PRESENILIN 1; PSEN1 PROTEIN, HUMAN; TAU PROTEIN; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN; BRAIN CORTEX; BRAIN INJURY; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DRUG EFFICACY; GENE MUTATION; GENETICS; HIPPOCAMPUS; HUMAN; HYPOTHESIS; METABOLISM; MOUSE; MUTANT; MUTATION; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE; TEMPORAL CORTEX; TRANSGENE; TRANSGENIC MOUSE;

EID: 0344845132     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.08.012     Document Type: Conference Paper

References (12)

1. Gotz J., Chen F., van Dorpe J., Nitsch R.M. Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Abeta 42 fibrils. Science. 293:2001;1491-1495.
2. Grundke-Iqbal I., Iqbal K., George L., Tung Y.C., Kim K.S., Wisniewski H.M. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86:1989;2853-2857.
3. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297:2002;353-356.
4. Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G.et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 293:2001;1487-1491.
5. Mesulam M.M. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron. 24:1999;521-529.
6. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R.et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron. 39:2003;409-421.
7. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N.et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:1996;864-870.
8. Schwab C., McGeer P.L. Abeta42-carboxyterminal-like immunoreactivity is associated with intracellular neurofibrillary tangles and pick bodies. Exp. Neurol. 161:2000;527-534.
9. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:2001;741-766.
10. Selkoe DJ, Podlisny MB. Deciphering the genetic basis of Alzheimer's disease. Annu Rev Genom Hum Genet 2002.
11. Sugarman M.C., Yamasaki T.R., Oddo S., Echegoyen J.C., Murphy M.P., Golde T.E.et al. Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 99(9):2002;6334-6339.
12. Wong P.C., Cai H., Borchelt D.R., Price D.L. Genetically engineered mouse models of neurodegenerative diseases. Nat. Neurosci. 5:2002;633-639.